Modern Healthspan: The Cardiovascular “Shield”: How GLP-1s Protect the Heart | Dr Mikhail Kolonin
Peer-Reviewed Research
Key Takeaways
- GLP-1 drugs reduce all-cause mortality by ~10%, primarily by lowering the risk of cardiovascular events like heart attacks and strokes.
- The protective effects of GLP-1 drugs mirror those seen with bariatric surgery, particularly in individuals with excess body fat.
- Focus on GLP-1 drugs for their ability to normalize health markers and reduce cardiovascular pathologies.
Notable Quotes
“All-cause mortality is decreased in people taking GLP-1 drugs by about 10% and that’s mainly by the reduction of MACE… heart disease, strokes, heart attacks.”
Bottom Line
Consider GLP-1 drugs as a potential therapeutic option for reducing cardiovascular risk and improving overall health, especially in individuals with excess body fat.
Explore More
- Modern Healthspan’s Full Protocol — supplements, dosages, and daily routine
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network